健肝消脂颗粒治疗非酒精性脂肪性肝病临床研究的开题报告VIP专享

精品文档---下载后可任意编辑健肝消脂颗粒治疗非酒精性脂肪性肝病(气滞血瘀型)临床讨论的开题报告【摘要】非酒精性脂肪性肝病（NAFLD）是一种多因素复合疾病，可导致肝功能紊乱和慢性肝炎。目前 NAFLD 的治疗方法存在局限性，因此寻求新的治疗方法具有重要意义。本讨论旨在探讨健肝消脂颗粒对气滞血瘀型NAFLD 的治疗效果及其机制。通过讨论证明，健肝消脂颗粒是一种中药复方，可以缓解 NAFLD 患者的症状，并通过促进脂肪代谢、改善肝功能等机制发挥治疗作用。本讨论将采纳随机对比实验设计，招募 50 例符合 NAFLD 诊断标准的气滞血瘀型患者，并随机分为治疗组和对比组，治疗组接受健肝消脂颗粒治疗，对比组接受安慰剂治疗。通过比较治疗前后的肝功能指标、血脂水平、肝脏组织学变化等指标的变化情况，评估健肝消脂颗粒对 NAFLD 的治疗效果及机制，并探讨其对临床实践的意义。【关键词】非酒精性脂肪性肝病；健肝消脂颗粒；气滞血瘀型；治疗效果；机制【Abstract】Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease that can cause liver dysfunction and chronic liver disease. Currently, the treatment of NAFLD is limited, so seeking new treatment methods is of great significance. This study aims to explore the therapeutic effect and mechanism of Jianhe Xiaoshi granule on qi stagnation and blood stasis type NAFLD.It is proved by research that Jianhe Xiaoshi granule, a Chinese patent medicine, can alleviate the symptoms of NAFLD patients and exert therapeutic effects through promoting fat metabolism, improving liver function and other mechanisms. This study will adopt a randomized controlled trial design, recruit 50 patients with qi stagnation and blood stasis type NAFLD according to the diagnostic criteria of NAFLD, and randomly divide them into treatment group and control group. The treatment group receives treatment with 精品文档---下载后可任意编辑Jianhe Xiaoshi granule, while the control group receives placebo treatment.By comparing the changes in liver function indicators, blood lipid levels, liver histological changes and other indicators before and after treatment, the therapeutic effect and mechanism of Jianhe Xiaoshi granule on NAFLD will be evaluated, and its significance for clinical practice will be explored.【Keywords】Non-alcoholic fatty liver disease; Jianhe Xiaoshi granule; qi stagnation and blood stasis type; therapeutic effect; mechanism